[1]
2020. Treatment with Human Urinary Kallidinogenase Improves Clinical Outcomes in Acute Ischemic Stroke Patients with Diabetes Mellitus. Current Research in Neurology and Neurosurgery. 3, 1 (Dec. 2020).